New Fast Antibody Test for Coronavirus Covid 19

Superbio SARS-CoV-2 IgM/IgG Antibody Fast Detection Kit
Minimum order is 4800 tests.
COVID 19 Test Kit from Wytcote
The Superbio Antibody test has been submitted to the FDA for Emergency Use Authorization (EUA) and submitted to the NIH for additional testing. The Superbio Antibody test has been validated.
wytcote covid test kits contents
Contents are contained within the sterile vacuum sealed pouches

Point of Care Test

Each test kit contains everything needed to carry out the in-vitro antibody test - no additional reagents needed and the sample does not need to be sent to a laboratory for analysis.

The test is carried out at the site of care, and the result appears in about 3 minutes.

Each box contains 20 test kits.


The test has been validated.
The antibody test was evaluated and compared to patient samples who were microbiologically confirmed to be Covid-19 positive or negative.
Get the Product Sheet

Specificity & Sensitivity


The ability of the test to accurately identify antibodies in confirmed Covid-19 negative patients were 98.5% and 98.15% respectively.

95.29% to 100%

The ability of the test to identify antibodies in confirmed Covid-19 positive patients in two studies were 100% and 95.2% respectively.

See the CHOC Children's Hospital Study

"While COVID-19 antibody screening is in its infancy, CHOC Children’s is pleased to help share data and contribute to this important conversation as the world’s scientific community unites in a race toward universal testing, antiviral treatment, and the development of a vaccine in order to permit a scientifically-based return to normalcy."
Dr. Terence Sanger
CHOC’s vice president of research and chief scientific officer.
Wytcote is registered with the FDA and has applied for use of this antibody test under the Emergency Use Authorization. Wytcote has submitted the test for independent validation by FDA/CDC/NIH.
• This test has not been reviewed by the FDA.
• Negative results do not rule out SARS-CoV-2 infection, particularly in those who have been in contact with the virus. Follow-up testing with a molecular diagnostic should be considered to rule out infection in these individuals.
• Results from antibody testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection or to inform infection status.
• Positive results may be due to past or present infection with non-SARS-CoV-2 coronavirus strains, such as coronavirus HKU1, NL63, OC43, or 229E.

Real Time Monitoring of Important Biometrics
Fully Compatible with WytCote's AutobahnTM
Secure Health Data Transmissions.
Personalized Care Anywhere
© Copyright 2020 - WytCote Technologies - All Rights Reserved
Corporate Headquarters

3 Park Plaza, Suite 480
Irvine CA 92614
(877) 472-5587

Science & Innovation Center
892 N. Fair Oaks Ave.,
Pasadena, CA 91103
earthbullhorn linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram